PLANET BIOTECHNOLOGY INCORPORATED
Doing business as PLANET BIOTECHNOLOGY
- HAYWARD, CA 94545
- planetbiotechnology.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM expiring
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $0
- Awards on record
- 0
- Contract vehicles
- 0
- Verified credentials
- 0
SAM.gov registration expires in 53 days
PLANET BIOTECHNOLOGY INCORPORATED’s registration expires on Jan 5, 2027. Renewal can take weeks; confirm it stays active through proposal submission and award.
View on SAM.gov (opens in a new tab)Learn more about SAM registration and the UEI
About PLANET BIOTECHNOLOGY INCORPORATED
- Headquarters
- HAYWARD, CA 94545
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIKTJKPBE2H5H3
- CAGE3GTX5
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
No federal prime awards on record
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 39 awards
- Total awarded
- $26,935,535
- By phase
- SBIR Phase I: 24
- SBIR Phase II: 8
- STTR Phase I: 7
- By agency
- Department of Health and Human Services: 36
- Department of Defense: 2
- Department of Agriculture: 1
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2024: 4
- 2023: 1
- 2022: 1
- 2020: 4
- 2019: 1
- 2018: 1
- 2017: 2
- 2015: 1
- 2014: 5
- 2013: 1
- 2012: 1
- 2011: 1
- 2010: 2
- 2009: 1
- 2008: 2
- 2007: 1
- 2006: 2
- 2005: 2
- 2004: 1
- 2003: 2
- 2002: 1
- 2001: 1
- 2000: 1
Awards (most recent first)
Bispecific antibody for topical administration to prevent gonorrhea
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2024 · $599,998
Aug 1, 2024 – Jul 31, 2026
Solicitation PA23-230 (2023) · Topic NIAID
Developing a Potent Broad-Spectrum Prophylactic for Tickborne Disease
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2024 · $600,000
Jul 17, 2024 – Jun 30, 2026
Solicitation PA23-232 (2023) · Topic NIAID · Research partner: TUFTS UNIVERSITY MEDFORD
Factor H-Fc Fusion as a Pre-Exposure Prophylactic for Rickettsia Infections
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2024 · $595,353
Jul 10, 2024 – Jun 30, 2026
Solicitation PA23-230 (2023) · Topic NIAID
A broad spectrum anti-gonorrhea immunotherapeutic
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2024 · $596,920
Apr 4, 2024 – Mar 31, 2026
Solicitation PA23-232 (2023) · Topic NIAID · Research partner: UNIV OF MASSACHUSETTS MED SCH WORCESTER
Factor H Fc fusions as novel therapeutics for Burkholderia pseudomallei infections
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2023 · $600,000
Aug 10, 2023 – Jul 31, 2025
Solicitation PA22-178 (2022) · Topic NIAID · Research partner: UNIVERSITY OF TOLEDO
FH-Fc as a Pre-Exposure Prophylactic for Tickborne Disease
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2022 · $2,000,000
May 16, 2022 – Apr 30, 2024
Solicitation PA21-259 (2021) · Topic NIAID
FH-Fc as a Pre-Exposure Prophylactic for Tickborne Disease
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $444,684
Jul 17, 2020 – Jun 30, 2022
Solicitation PA19-270 (2019) · Topic NIAID · Research partner: UNIVERSITY OF NORTH DAKOTA
Recombinant Fc fusions for treatment of uropathogenic E. coli
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $486,870
Apr 1, 2020 – Mar 31, 2021
Solicitation PA19-270 (2019) · Topic 300 · Research partner: UNIVERSITY OF WASHINGTON
An immunotherapeutic to prevent gonorrhea
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2020 · $1,727,108
Mar 11, 2020 – Feb 28, 2022
Solicitation PA18-574 (2018) · Topic NIAID
Improving gene expression via Massively Parallel Synonymous Codon Variant Screening
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $298,634
Mar 1, 2020 – Feb 28, 2021
Solicitation PA18-574 (2018) · Topic 400
An immunotherapeutic to prevent gonorrhea
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $300,000
Aug 1, 2019 – Jan 31, 2020
Solicitation PA18-574 (2018) · Topic NIAID
An immunoadhesin therapy for glioblastoma targeting CD97
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $263,999
Jul 4, 2018 – Jun 30, 2019
Solicitation PA17-302 (2017) · Topic 102
A mucosally targeted MERS CoV vaccine produced in plants
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $236,488
Feb 17, 2017 – Mar 31, 2018
Solicitation PA15-269 (2015) · Topic NIAID
A novel anti gonorrhea immunotherapeutic
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $242,093
Feb 13, 2017 – Mar 31, 2018
Solicitation PA15-270 (2015) · Topic NIAID · Research partner: UNIV OF MASSACHUSETTS MED SCH WORCESTER
A MERS-CoV Receptor Decoy
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2015 · $1,575,242
Aug 14, 2015 – Jan 31, 2018
Solicitation PA14-071 (2014) · Topic NIAID
Lab research for the development of anti-diphetheria antibodies in humans
SBIR Phase I · Department of Health and Human Services (Centers for Disease Control and Prevention) · 2014 · $150,000
Aug 1, 2014 – Mar 15, 2015
A MERS-CoV Receptor Decoy
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $225,000
Solicitation PA13-234 (2014) · Topic NIAID · Research partner: Stub
A Cell-Penetrating Anthrax Antitoxin
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $219,367
Solicitation PA13-234 (2014) · Topic NIAID · Research partner: Stub
Targeted mutagenesis of plant genes by the CRISPR/Cas system
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $224,126
Solicitation PA13-234 (2014) · Topic NIGMS · Research partner: Stub
Exploiting Superinfection Exclusion To Express Polyclonal Antibodies In Plants
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $224,999
Solicitation PA13-234 (2014) · Topic NIGMS · Research partner: Stub
Enhanced Recovery of Pharmaceutical Solvent driven by EPA Initiative
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $276,767
Solicitation PA12-088 (2013) · Topic NCI · Research partner: Stub
An immunoadhesin for treatment of hypercholesterolemia
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $282,629
Solicitation PA11-096 (2012) · Topic NHLBI · Research partner: Stub
Plant-Made Nanobodies for Botulism Treatment
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2011 · $236,847
Solicitation PA10-050 (2011) · Topic NIAID · Research partner: Stub
Novel Therapy for Pulmonary Anthrax
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2010 · $3,000,000
Solicitation PHS2010-2 (2010) · Topic NIAID
Maximizing Expression of Immunoglobulins in Plants
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2010 · $797,961
Solicitation PHS2010-2 (2010) · Topic NIGMS
Showing the 25 most recent of 39 awards.
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)Primary
- 325411Title not in the curated list
- 325413Title not in the curated list
- 325414Biological Product (except Diagnostic) Manufacturing
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with PLANET BIOTECHNOLOGY INCORPORATED?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.